Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Zydus wins FDA nod for DMD drug Jaythari—what it means for rare disease treatment and its stock Find out how Zydus Lifesciences is expanding rare disease care and investor value with USFDA-approved Jaythari tablets for Duchenne muscular dystrophy. byPallavi MadhirajuApril 12, 2025